For citations:
SEMIGLAZOVA TY, ZHABINA AS, BELYAEVA АV, KLUGE VA, USOVA KV, LATIPOVA DH, TELETAEVA GM, NOVIK AV, SEMENOVA AI, PROTSENKO SA. TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS. Meditsinskiy sovet = Medical Council. 2016;(10):56-65. (In Russ.) https://doi.org/10.21518/2079-701X-2016-10-56-65